Table 4. Association between LUTS/BPE medication use and IPP.
Unadjusted OR (95% CI) | Adjusted OR (95% CI)* | |
---|---|---|
IPP (mm): | ||
Less than 10 | 1.00 | 1.00 |
10 or Greater | 3.25 (1.53–6.93) | 2.95 (1.23–7.06) |
Age: | ||
50–59 | 1.00 | 1.00 |
60–69 | 0.89 (0.42–1.88) | 0.94 (0.42–2.15) |
70+ | 2.18 (1.03–4.64) | 1.52 (0.66–3.51) |
Symptom score: | ||
7 or Less | 1.00 | 1.00 |
Greater than 7 | 6.00 (3.01–11.95) | 3.37 (1.43–7.98) |
Bother score: | ||
3 or Less | 1.00 | 1.00 |
Greater than 3 | 3.86 (2.17–6.88) | 1.95 (0.94–4.05) |
Peak flow rate (ml/sec): | ||
12 or Greater | 1.00 | 1.00 |
Less than 12 | 2.33 (1.33–4.07) | 1.38 (0.74–2.57) |
Prostate vol (ml): | ||
30 or Less | 1.00 | 1.00 |
Greater than 30 | 2.28 (1.29–4.02) | 1.56 (0.82–3.00) |
Odds ratios adjusted for all variables in the table.